Development of a novel equine influenza virus live-attenuated vaccine

Virology

Volumn 516, Issue , 2018, Pages 76-85

  Rodriguez, Laura ^a   Reedy, Stephanie ^b   Nogales, Aitor ^a   Murcia, Pablo R ^c   Chambers, Thomas M ^b   Martinez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Attenuated (att); Equine influenza virus (EIV); Influenza A virus (IAV); Live attenuated influenza vaccine (LAIV); Master donor virus (MDV); Reverse genetics techniques; Temperature sensitive (ts)

Indexed keywords

FLU AVERT; INFLUENZA VACCINE; LIVE VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBRYO; ENZYME ACTIVITY; EQUINE INFLUENZA (H3N8); FEASIBILITY STUDY; FEMALE; GENETIC TRANSCRIPTION; HEK293T CELL LINE; HORSE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION CONTROL; INFLUENZA A VIRUS (H3N8); MALE; MDCK CELL LINE; MOUSE; NBL 6 CELL LINE; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; SKIN CELL LINE; TEMPERATURE; TEMPERATURE SENSITIVITY; VIRUS REPLICATION; ZYGOTE; ANIMAL; C57BL MOUSE; GENETICS; HORSE DISEASE; IMMUNOLOGY; ORTHOMYXOVIRUS INFECTION; VACCINATION; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; REVERSE GENETICS; VACCINATION; VACCINES, ATTENUATED;

EID: 85042878902     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2018.01.005     Document Type: Article

References (70)

1. Alves Beuttemmuller, E., Woodward, A., Rash, A., Dos Santos Ferraz, L.E., Fernandes Alfieri, A., Alfieri, A.A., Elton, D., Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virol. J., 13, 2016, 45.
2. Baker, S.F., Guo, H., Albrecht, R.A., Garcia-Sastre, A., Topham, D.J., Martinez-Sobrido, L., Protection against Lethal Influenza with a Viral Mimic. J. Virol. 87 (2013), 8591–8605.
3. Baz, M., Paskel, M., Matsuoka, Y., Zengel, J., Cheng, X., Treanor, J.J., Jin, H., Subbarao, K., A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. J. Virol. 89 (2015), 1652–1659.
4. Belongia, E.A., Kieke, B.A., Donahue, J.G., Greenlee, R.T., Balish, A., Foust, A., Lindstrom, S., Shay, D.K., Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J. Infect. Dis. 199 (2009), 159–167.
5. Belshe, R.B., Edwards, K.M., Vesikari, T., Black, S.V., Walker, R.E., Hultquist, M., Kemble, G., Connor, E.M., Group, C.-T.C.E.S., Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356 (2007), 685–696.
6. Bryant, N.A., Rash, A.S., Russell, C.A., Ross, J., Cooke, A., Bowman, S., MacRae, S., Lewis, N.S., Paillot, R., Zanoni, R., Meier, H., Griffiths, L.A., Daly, J.M., Tiwari, A., Chambers, T.M., Newton, J.R., Elton, D.M., Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 138 (2009), 41–52.
7. Chambers, T.M., Holland, R.E., Tudor, L.R., Townsend, H.G., Cook, A., Bogdan, J., Lunn, D.P., Hussey, S., Whitaker-Dowling, P., Youngner, J.S., Sebring, R.W., Penner, S.J., Stiegler, G.L., A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet. J. 33 (2001), 630–636.
8. Chambers, T.M., Quinlivan, M., Sturgill, T., Cullinane, A., Horohov, D.W., Zamarin, D., Arkins, S., Garcia-Sastre, A., Palese, P., Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet. J. 41 (2009), 87–92.
9. Chambers, T.M., Reedy, S.E., Equine influenza serological methods. Methods Mol. Biol. 1161 (2014), 411–422.
10. Chan, W., Zhou, H., Kemble, G., Jin, H., The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virology 380 (2008), 304–311.
11. Cheng, B.Y., Ortiz-Riano, E., Nogales, A., de la Torre, J.C., Martinez-Sobrido, L., Development of live-attenuated arenavirus vaccines based on codon deoptimization. J. Virol. 89 (2015), 3523–3533.
12. Cheng, X., Zengel, J.R., Suguitan, A.L. Jr., Xu, Q., Wang, W., Lin, J., Jin, H., Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J. Infect. Dis. 208 (2013), 594–602.
13. Cowled, B., Ward, M.P., Hamilton, S., Garner, G., The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic. Prev. Vet. Med. 92 (2009), 60–70.
14. Cox, A., Baker, S.F., Nogales, A., Martinez-Sobrido, L., Dewhurst, S., Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine. J. Virol. 89 (2015), 3421–3426.
15. Cox, N.J., Kitame, F., Kendal, A.P., Maassab, H.F., Naeve, C., Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 167 (1988), 554–567.
16. Cullinane, A., Elton, D., Mumford, J., Equine influenza - surveillance and control. Influenza Other Respir. Virus. 4 (2010), 339–344.
17. Daly, J.M., Lai, A.C., Binns, M.M., Chambers, T.M., Barrandeguy, M., Mumford, J.A., Antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 77:Pt 4 (1996), 661–671.
18. Daly, J.M., MacRae, S., Newton, J.R., Wattrang, E., Elton, D.M., Equine influenza: a review of an unpredictable virus. Vet. J. 189 (2011), 7–14.
19. Daly, J.M., Yates, R.J., Browse, G., Swann, Z., Newton, J.R., Jessett, D., Davis-Poynter, N., Mumford, J.A., Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet. J. 35 (2003), 458–462.
20. De Villiers, P.J., Steele, A.D., Hiemstra, L.A., Rappaport, R., Dunning, A.J., Gruber, W.C., Forrest, B.D., Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 28 (2009), 228–234.
21. Fougerolle, S., Legrand, L., Lecouturier, F., Sailleau, C., Paillot, R., Hans, A., Pronost, S., Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors. Virology 505 (2017), 210–217.
22. Garner, M.G., Cowled, B., East, I.J., Moloney, B.J., Kung, N.Y., Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza–a modelling approach. Prev. Vet. Med. 99 (2011), 15–27.
23. Gorse, G.J., Belshe, R.B., Munn, N.J., Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults. Chest 100 (1991), 977–984.
24. Guo, H., Baker, S.F., Martinez-Sobrido, L., Topham, D.J., Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus. J. Virol. 88 (2014), 12006–12016.
25. Hoft, D.F., Babusis, E., Worku, S., Spencer, C.T., Lottenbach, K., Truscott, S.M., Abate, G., Sakala, I.G., Edwards, K.M., Creech, C.B., Gerber, M.A., Bernstein, D.I., Newman, F., Graham, I., Anderson, E.L., Belshe, R.B., Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 204 (2011), 845–853.
26. Jin, H., Zhou, H., Lu, B., Kemble, G., Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J. Virol. 78 (2004), 995–998.
27. Katsura, H., Iwatsuki-Horimoto, K., Fukuyama, S., Watanabe, S., Sakabe, S., Hatta, Y., Murakami, S., Shimojima, M., Horimoto, T., Kawaoka, Y., A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine. Vaccine 30 (2012), 6027–6033.
28. Kohlmeier, J.E., Woodland, D.L., Immunity to respiratory viruses. Annu Rev. Immunol. 27 (2009), 61–82.
29. Lai, A.C., Chambers, T.M., Holland, R.E. Jr., Morley, P.S., Haines, D.M., Townsend, H.G., Barrandeguy, M., Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch. Virol. 146 (2001), 1063–1074.
30. Lu, Z., Chambers, T.M., Boliar, S., Branscum, A.J., Sturgill, T.L., Timoney, P.J., Reedy, S.E., Tudor, L.R., Dubovi, E.J., Vickers, M.L., Sells, S., Balasuriya, U.B., Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus. J. Clin. Microbiol. 47 (2009), 3907–3913.
31. Lunn, D.P., Hussey, S., Sebing, R., Rushlow, K.E., Radecki, S.V., Whitaker-Dowling, P., Youngner, J.S., Chambers, T.M., Holland, R.E. Jr., Horohov, D.W., Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J. Am. Vet. Med. Assoc. 218 (2001), 900–906.
32. Martinez-Sobrido, L., Garcia-Sastre, A., Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp., 2010.
33. Mumford, J.A., Hannant, D., Jessett, D.M., Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet. J. 22 (1990), 93–98.
34. Murcia, P.R., Wood, J.L., Holmes, E.C., Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J. Virol. 85 (2011), 5312–5322.
35. Murphy, B.R., Coelingh, K., Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15 (2002), 295–323.
36. National Research Council (U.S.), Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.). Guide for the Care And Use Of Laboratory Animals. 8th ed., 2011, National Academies Press, Washington, D.C.
37. Nogales, A., Baker, S.F., Martinez-Sobrido, L., Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476C (2014), 206–216.
38. Nogales, A., Baker, S.F., Ortiz-Riano, E., Dewhurst, S., Topham, D.J., Martinez-Sobrido, L., Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. J. Virol. 88 (2014), 10525–10540.
39. Nogales, A., DeDiego, M.L., Topham, D.J., Martinez-Sobrido, L., Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines. J. Virol. 90 (2016), 6291–6302.
40. Nogales, A., Huang, K., Chauche, C., DeDiego, M.L., Murcia, P.R., Parrish, C.R., Martinez-Sobrido, L., Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines. Virology 500 (2017), 1–10.
41. Nogales, A., Rodriguez, L., Chauche, C., Huang, K., Reilly, E.C., Topham, D.J., Murcia, P.R., Parrish, C.R., Martinez-Sobrido, L., A temperature sensitive live-attenuated canine influenza virus H3N8 vaccine. J. Virol., 2016, 91.
42. OIE, 2017. OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition, OIE Headquarters, 22 March 2017. 〈http://www.oie.int/en/our-scientific-expertise/specific-information-and-recommendations/equine-influenza/〉.
43. Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12 (2012), 36–44.
44. Paillot, R., A systematic review of Recent Advances in equine influenza vaccination. Vaccines 2 (2014), 797–831.
45. Paillot, R., Rash, N.L., Garrett, D., Prowse-Davis, L., Montesso, F., Cullinane, A., Lemaitre, L., Thibault, J.C., Wittreck, S., Dancer, A., How to meet the last OIE expert surveillance panel recommendations on Equine Influenza (EI) vaccine composition: a review of the process required for the recombinant Canarypox-based EI vaccine. Pathogens, 2016, 5.
46. Palese, P., Shaw, M.L., Orthomyxoviridae: the viruses and their replication. Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., (eds.) Fields Virology, 5th edition, 2007, Lippincott Williams and WIlkins.
47. Park, A.W., Daly, J.M., Lewis, N.S., Smith, D.J., Wood, J.L., Grenfell, B.T., Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326 (2009), 726–728.
48. Pica, N., Palese, P., Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 64 (2013), 189–202.
49. Powell, T.J., Silk, J.D., Sharps, J., Fodor, E., Townsend, A.R., Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity. J. Virol. 86 (2012), 13397–13406.
50. Qi, T., Guo, W., Huang, W.Q., Li, H.M., Zhao, L.P., Dai, L.L., He, N., Hao, X.F., Xiang, W.H., Genetic evolution of equine influenza viruses isolated in China. Arch. Virol. 155 (2010), 1425–1432.
51. Rash, A., Morton, R., Woodward, A., Maes, O., McCauley, J., Bryant, N., Elton, D., Evolution and divergence of H3N8 EQuine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015. Pathogens, 2017, 6.
52. Rodriguez, L., Nogales, A., Martinez-Sobrido, L., Influenza A virus studies in a mouse model of infection. J. Vis. Exp., 2017.
53. Rodriguez, L., Nogales, A., Murcia, P.R., Parrish, C.R., Martinez-Sobrido, L., A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses. Vaccine 35 (2017), 4374–4381.
54. Rodriguez, L., Nogales, A., Reilly, E.C., Topham, D.J., Murcia, P.R., Parrish, C.R., Martinez Sobrido, L., A live-attenuated influenza vaccine for H3N2 canine influenza virus. Virology 504 (2017), 96–106.
55. Snyder, M.H., Betts, R.F., DeBorde, D., Tierney, E.L., Clements, M.L., Herrington, D., Sears, S.D., Dolin, R., Maassab, H.F., Murphy, B.R., Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J. Virol. 62 (1988), 488–495.
56. Suguitan, A.L. Jr., McAuliffe, J., Mills, K.L., Jin, H., Duke, G., Lu, B., Luke, C.J., Murphy, B., Swayne, D.E., Kemble, G., Subbarao, K., Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med., 3, 2006, e360.
57. Timoney, P.J., Factors influencing the international spread of equine diseases. Vet. Clin. North Am. Equine Pract. 16 (2000), 537–551 (x).
58. Townsend, H.G., Penner, S.J., Watts, T.C., Cook, A., Bogdan, J., Haines, D.M., Griffin, S., Chambers, T., Holland, R.E., Whitaker-Dowling, P., Youngner, J.S., Sebring, R.W., Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet. J. 33 (2001), 637–643.
59. Uraki, R., Kiso, M., Iwatsuki-Horimoto, K., Fukuyama, S., Takashita, E., Ozawa, M., Kawaoka, Y., A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges. J. Virol. 87 (2013), 7874–7881.
60. Victor, S.T., Watanabe, S., Katsura, H., Ozawa, M., Kawaoka, Y., A replication-incompetent PB2-knockout influenza A virus vaccine vector. J. Virol., 2012.
61. Virmani, N., Bera, B.C., Singh, B.K., Shanmugasundaram, K., Gulati, B.R., Barua, S., Vaid, R.K., Gupta, A.K., Singh, R.K., Equine influenza outbreak in India (2008–09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet. Microbiol. 143 (2010), 224–237.
62. Waddell, G.H., Teigland, M.B., Sigel, M.M., A new influenza virus associated with equine respiratory disease. J. Am. Vet. Med. Assoc. 143 (1963), 587–590.
63. Wilson, W.D., Robinson, D., Field safety of a modified-live, cold-adapted intranasal equine influenza vaccine (HESKAFlu Avert IN vaccine) in horses. J. Equine Vet. Sci. 20 (2000), 8–10.
64. Wong, S.S., Webby, R.J., Traditional and new influenza vaccines. Clin. Microbiol. Rev. 26 (2013), 476–492.
65. Woodward, A.L., Rash, A.S., Blinman, D., Bowman, S., Chambers, T.M., Daly, J.M., Damiani, A., Joseph, S., Lewis, N., McCauley, J.W., Medcalf, L., Mumford, J., Newton, J.R., Tiwari, A., Bryant, N.A., Elton, D.M., Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010–2012. Vet. Microbiol. 169 (2014), 113–127.
66. Yamanaka, T., Niwa, H., Tsujimura, K., Kondo, T., Matsumura, T., Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J. Vet. Med. Sci. 70 (2008), 623–625.
67. Yates, P., Mumford, J.A., Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 74 (2000), 173–177.
68. Yondon, M., Heil, G.L., Burks, J.P., Zayat, B., Waltzek, T.B., Jamiyan, B.O., McKenzie, P.P., Krueger, W.S., Friary, J.A., Gray, G.C., Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respir. Virus. 7 (2013), 659–665.
69. Youngner, J.S., Whitaker-Dowling, P., Chambers, T.M., Rushlow, K.E., Sebring, R., Derivation and characterization of a live attenuated equine influenza vaccine virus. Am. J. Vet. Res. 62 (2001), 1290–1294.
70. Zhou, B., Li, Y., Speer, S.D., Subba, A., Lin, X., Wentworth, D.E., Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses. Vaccine 30 (2012), 3691–3702.